China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products
On June 27, 2019, China Medical System Holdings Ltd. ("China Medical System" or the "Company") announced that the Company introduced Tildrakizumab, a product used...
MIT’s research enterprise in Singapore launches new research group, boosting nation’s cell therapies R&D
MIT's Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore's National Cell Manufacturing...
TransCanna Terminates Transaction with Lifestyle Delivery Systems Inc.
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") and Lifestyle Delivery Systems Inc. (CSE: LDS) (FSE: LD6) (WKN: A14XHT) (OTCQX: LDSYF)...
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS)....
With ROE of Over 20% for a Decade While the Stock Price Falling by...
If there is an indicator to measure whether the company is good or not from Buffett's perspective, it's believed that most investors will...
TransCanna Acquires The GoodFellas Group, LLC
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (OTC PINK: TCNAF) ("TransCanna" or the "Company") announces that it has signed a definitive acquisition agreement dated...
Highlights from TransCanna Investor Call; Accelerated Execution Against Strategy
Below is a summary of the conference call held July 3, 2019 with investors, and TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE:...
TransCanna To Provide Corporate Update on Conference Call
TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE: TH8) ("TransCanna" or the "Company") will be providing a corporate update to its shareholders and...
TransCanna Signs Exclusive Agreement To Acquire 100% Of Lifestyle Delivery and CannaStrips(TM)
TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE: TH8) ("TransCanna" or the "Company") and Lifestyle Delivery Systems Inc. (CSE: LDS) (FSE: LD6) (WKN:...
Singapore’s Drug Development Efforts Given Additional Momentum with National Platforms
The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery...
Jacobson Pharma Announces FY2019 Annual Results
Profit Attributable to Shareholders Increased by 23.9% to a Record High of HK$250.6 Million;
Total Dividend Up 18.4% to HK4.5 Cents per Share
Jacobson...
TransCanna Hires General Manager for Its 196,000 Sq Ft Facility; Bringing Decades of Experience...
TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE: TH8) ("TransCanna" or the "Company") has hired Alan R. Applonie as General Manager. Alan will...
Global BioLife’s new mosquito repellent formula performs well against mosquitos in independent testing
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has...
TransCanna Announces Closing of CDN$10 Million Brokered Private Placement of Units
TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (OTC PINK: TCNAF) ("TransCanna" or the "Company") is pleased to announce that it has closed its previously...
PromarkerD features at American Diabetes Association 79th Scientific Sessions saying diabetics deserve to know...
Proteomics International meeting with US tier 1 national diagnostic groups to expand global roll-out of PromarkerD including EU and Mexico
Proteomics International (ASX: PIQ) has...
Proteomics International and PromarkerD at BIO 2019 saying 30 million diabetics in US deserve...
PromarkerD world's leading diagnostic test for diabetic kidney disease says Frost & Sullivan industry report 'Biomarkers Enabling Diabetes and Obesity Management'
Proteomics International (PILL; ASX:...
노보텍, ASCO에서 올해의 아시아태평양 생명과학 CRO상 수상
아시아태평양 전문 임상시험수탁기관(CRO) 노보텍(Novotech)이 선도적인 분석 업체 프로스트&설리번(Frost & Sullivan)이 수여하는 올해의 아시아태평양 CRO 상을 받는 영예를 다시 한번 안았다.
노보텍이 올해로 다섯 번째 수상한...
Novotech Awarded Asia-Pacific Biotech CRO of the Year – Announced at ASCO
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is...
Sino Biopharmaceutical Announces 2019 First Quarterly Results
Revenue Up 33.4% to RMB6,208 Million
Underlying Profit* Climbs 22.4% to RMB976 Million
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the...
Mabpharm Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
Offer Price Set Between HK$1.50 to HK$1.95 per Share, To Raise Gross Proceeds Up to HK$1,528 Million
A Leading Biopharmaceutical Company in China,...
